Georg Schett
In recent years, the new immune-based therapy CAR T has dramatically improved outcomes for patients with certain blood cancers that involve B cells, like leukemia and lymphoma. Dr. Georg Schett, a rheumatologist at the University Hospital Erlangen in Germany, saw the potential of the treatment for autoimmune diseases like lupus, in which immune B cells attack the body’s own cells. He performed the first CAR T treatments on five patients with the disease in 2022, but “nobody knew whether it would work,” he says. Eight months after receiving the therapy, all five were in remission and no longer needed power...
Source: TIME: Health - May 2, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Accolades franchise Magazine Special Project sponsorshipblock time100health2024 Source Type: news
50 years of EPI ’s extraordinary impact on global health
24 April 2024, Cairo, Egypt – World Immunization Week this year coincides with the 50th anniversary of the Expanded Programme on Immunization (EPI). Such has been the programme’s remarkable impact on global health that the “E” in EPI today stands for “Essential”.
Since 1974, this WHO initiative has inspired countries to use vaccines to do everything humanly possible to safeguard the health and well-being of all children everywhere.
Dr Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, emphasized the importance of equitable access to vaccines: “EPI has been instrumental in saving mi...
Source: WHO EMRO News - May 1, 2024 Category: Middle East Health Source Type: news
Opening statement by Director of Programme Management at the World Immunization Week press ...
Distinguished guests, esteemed colleagues, and members of the media,
We warmly welcome you to this press conference to mark World Immunization Week. This year, the week coincides with a remarkable milestone – 50 years of the Expanded Programme on Immunization, or EPI.
When launched in 1974, this WHO initiative started out with a limited series of vaccines against just six childhood diseases. Today, EPI offers protection against 13 vaccine-preventable diseases, reflecting the initiative’s incredible progress.
Here in the Eastern Mediterranean Region, more than 25 million lives have been saved thanks to the power of v...
Source: WHO EMRO News - April 29, 2024 Category: Middle East Health Source Type: news
What Causes Hemoptysis?
Discussion
True hemoptysis is a very uncommon or rare problem in pediatrics but can be potentially life-threatening. Massive hemoptysis has a high mortality (up to 50%) mainly from asphyxia and inability to ventilate and oxygenate the patient because of blood in the pulmonary airways. Fortunately, most hemoptysis is small in amount that resolves within 24 hours.
Initial evaluation for hemoptysis can include complete blood count, coagulation studies, C-reactive protein, erythrocyte sedimentation rate, urinalysis (possible pulmonary-renal problems), radiographic imaging including chest x-ray and/or computed tomography, and...
Source: PediatricEducation.org - April 22, 2024 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Is Pfizer Stock, At A 9-Year Low, A Sell Amid The Search For Its Big Break?
stock is trading at a nine-year low as the drugmaker looks for its next big break after developing the first Covid vaccine with Germany's BioNTech (BNTX). Last month, the European Commission approved Pfizer's Prevnar 20, a vaccine to help protect babies and children from pneumococcal disease. The…#bntx #europeancommission #pfizer #prevnar20 #adcetris #seagen #adcentris #rsva #gsk #arexvy (Source: Reuters: Health)
Source: Reuters: Health - April 18, 2024 Category: Consumer Health News Source Type: news
The Most Exciting New Advances in Managing COPD
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National Institutes of Health and the World Health Organization, one of GOLD’s stated aims is to “improve prevention and treatment of this lung disease.”
In its 2023 global strategy report, GOLD changed its definition of COPD—which many in the profession viewed as overdue. Specifically, the new definition emphasized the heterogeneity of COPD in terms of its underlying drivers and long-term disease course.
[ti...
Source: TIME: Health - March 18, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance Source Type: news
European Commission approves Pfizer & #039;s PREVENAR 20 ® to help protect infants and children against pneumococcal disease
Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company's 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. (Source: World Pharma News)
Source: World Pharma News - March 13, 2024 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
From COVID-19 to Measles, Florida ’ s War on Public Health
The culture of public health and medicine rests on open discussions in which different points of view are considered for the betterment of patient care and health. This process depends on psychological safety so individuals feel free and safe to speak and openly disagree. These factors collectively create a just culture, which improves systems and organizations and is being widely implemented in healthcare nationwide.
[time-brightcove not-tgx=”true”]
However, in the face of politicized anti-science and anti-expert sentiment and attacks, we need to ask if just culture is being restricted in public health. Fo...
Source: TIME: Health - February 27, 2024 Category: Consumer Health News Authors: Scott A. Rivkees Tags: Uncategorized freelance Source Type: news
Holiday Gatherings and a New Variant Are Fueling COVID-19 Deaths, WHO Says
GENEVA — The head of the U.N. health agency said Wednesday holiday gatherings and the spread of the most prominent variant globally led to increased transmission of COVID-19 last month.
Tedros Adhanom Ghebreyesus said nearly 10,000 deaths were reported in December, while hospital admissions during the month jumped 42% in nearly 50 countries—mostly in Europe and the Americas—that shared such trend information.
[time-brightcove not-tgx=”true”]
“Although 10,000 deaths a month is far less than the peak of the pandemic, this level of preventable deaths is not acceptable,” the Wor...
Source: TIME: Health - January 11, 2024 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
When Should We Consider A Rickettsial Disease?
Discussion
Rickettsioses are “small, obligate intracellular, gram-negative, aerobic coccobacillary α-proeobacteria” from the genuses Rickettsia, Anaplasma, Coxiella, Ehrlichia, and Orientia genuses. Often they cause limited health problems but can cause severe disease and death. They present with a fever and other non-specific signs and symptoms, usually with a rash and lymphadenopathy. Other problems can include:
Cardiac – endocarditis, myocarditis, pericarditis
Gastrointestinal – abdominal pain, acute abdomen, cholecystitis, hepatitis, pancreatitis
Heme/Lymph – hemophagocytosis, lymph...
Source: PediatricEducation.org - December 18, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Getting Sick All the Time? Don ’ t (Necessarily) Blame COVID-19
Respiratory disease season is in full swing, with influenza, RSV, and COVID-19 case counts rising in various parts of the U.S. Hospitals in some states are also reporting upticks in pediatric pneumonia diagnoses, which experts say seems to be unrelated to the recent spike of pneumonias reported in China.
On the heels of last year’s severe flu and RSV reason, all this contagion has some people wondering if SARS-CoV-2, the virus that causes COVID-19, may be to blame. Some studies suggest the virus leaves its mark on the immune system even after an acute illness passes, raising an important question: does having COVI...
Source: TIME: Health - December 7, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Texas Sues Pfizer Over Vax Claims; Dr. Rand Paul to the Rescue; Kid Pneumonia Cases
(MedPage Today) -- Note that some links may require registration or subscription.
Texas Attorney General Ken Paxton has sued Pfizer over the drugmaker's efficacy claims for its COVID vaccine. (Reuters)
Sen. Rand Paul, MD (R-Ky.), rushed to the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 1, 2023 Category: American Health Source Type: news
Notes from the Field: A Cluster of Multi-Strain Invasive Pneumococcal Disease Among Persons Experiencing Homelessness and Use of Pneumococcal Conjugate Vaccine - El Paso County, Colorado, 2022
This report describes cases of invasive pneumococcal disease among people experiencing homelessness in Colorado. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 16, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Provider Knowledge of Pneumococcal Vaccine Recommendations Provider Knowledge of Pneumococcal Vaccine Recommendations
Pneumococcal vaccine coverage remains low. This survey found that many health care providers are confused about the nuances surrounding recommendations for pneumococcal vaccine for adult patients.Morbidity & Mortality Weekly Report (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 15, 2023 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news
Here ’s How the CDC Will Track Viruses Over the Holiday Travel Season
If you’ve traveled overseas recently, you might have been greeted upon your return by people in a handful of airport terminals in the U.S. recruiting passengers to get tested for the COVID-19 virus. It’s been a surprisingly productive way to keep track of how much COVID-19 might be entering the country, via travelers, as well as which variants they are bringing in.
Just in time for the busy holiday travel season, the program’s operators, the Centers for Disease Control and Prevention (CDC), Concentric by Ginkgo Bioworks (a Boston-based biotech firm), and XpresCheck, which recruits and tests the passeng...
Source: TIME: Health - November 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
